ICU Medical, Incorporated (ICUI) Shares Sold by Gamco Investors INC. ET AL

Gamco Investors INC. ET AL trimmed its position in ICU Medical, Incorporated (NASDAQ:ICUI) by 10.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 34,825 shares of the medical instruments supplier’s stock after selling 4,250 shares during the quarter. Gamco Investors INC. ET AL’s holdings in ICU Medical were worth $9,847,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Meeder Asset Management Inc. grew its stake in ICU Medical by 85.0% during the 3rd quarter. Meeder Asset Management Inc. now owns 1,935 shares of the medical instruments supplier’s stock worth $546,000 after buying an additional 889 shares during the last quarter. Commerce Bank grew its stake in ICU Medical by 85.6% during the 3rd quarter. Commerce Bank now owns 9,955 shares of the medical instruments supplier’s stock worth $2,815,000 after buying an additional 4,591 shares during the last quarter. Wells Fargo & Company MN grew its stake in ICU Medical by 15.6% during the 3rd quarter. Wells Fargo & Company MN now owns 507,855 shares of the medical instruments supplier’s stock worth $143,595,000 after buying an additional 68,347 shares during the last quarter. Chicago Equity Partners LLC grew its stake in ICU Medical by 48.4% during the 3rd quarter. Chicago Equity Partners LLC now owns 11,970 shares of the medical instruments supplier’s stock worth $3,385,000 after buying an additional 3,905 shares during the last quarter. Finally, Signition LP bought a new position in ICU Medical during the 3rd quarter worth $251,000. Institutional investors and hedge funds own 73.51% of the company’s stock.

In other news, VP Virginia Ruth Sanzone sold 787 shares of the stock in a transaction on Tuesday, August 28th. The stock was sold at an average price of $303.12, for a total value of $238,555.44. Following the completion of the transaction, the vice president now owns 1,367 shares of the company’s stock, valued at $414,365.04. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Pfizer Inc sold 700,000 shares of the stock in a transaction on Monday, August 13th. The stock was sold at an average price of $284.35, for a total value of $199,045,000.00. The disclosure for this sale can be found here. In the last three months, insiders sold 711,920 shares of company stock valued at $202,651,956. Company insiders own 12.50% of the company’s stock.

A number of brokerages recently commented on ICUI. Zacks Investment Research downgraded ICU Medical from a “buy” rating to a “hold” rating in a research note on Saturday. ValuEngine downgraded ICU Medical from a “strong-buy” rating to a “buy” rating in a research note on Friday, August 3rd. BidaskClub downgraded ICU Medical from a “strong-buy” rating to a “buy” rating in a research note on Thursday, September 20th. Finally, TheStreet upgraded ICU Medical from a “c+” rating to a “b+” rating in a research note on Monday, August 20th.

Shares of ICUI opened at $232.01 on Friday. The firm has a market cap of $5.31 billion, a P/E ratio of 35.99 and a beta of 0.65. ICU Medical, Incorporated has a 12 month low of $196.33 and a 12 month high of $321.70.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings data on Thursday, November 8th. The medical instruments supplier reported $1.85 EPS for the quarter, topping the Zacks’ consensus estimate of $1.51 by $0.34. ICU Medical had a return on equity of 12.78% and a net margin of 5.93%. The firm had revenue of $327.20 million during the quarter, compared to the consensus estimate of $334.97 million. During the same period in the prior year, the business earned $1.12 EPS. The firm’s revenue was down 4.7% on a year-over-year basis. On average, analysts anticipate that ICU Medical, Incorporated will post 7.6 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This story was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://sportsperspectives.com/2018/11/10/icu-medical-incorporated-icui-shares-sold-by-gamco-investors-inc-et-al.html.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Further Reading: What are the Different Types of Leveraged Buyouts?

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply